- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharma exports from India rise by 4.22 percent to USD 14.57 billion during April-Oct in current fiscal
![Pharma exports from India rise by 4.22 percent to USD 14.57 billion during April-Oct in current fiscal Pharma exports from India rise by 4.22 percent to USD 14.57 billion during April-Oct in current fiscal](https://medicaldialogues.in/h-upload/2022/11/28/750x450_192163-pharma-exports.webp)
India's overall exports contracted by 16.65 percent to USD 29.78 billion in October 2022 as compared to the last year's period, according to data released by the Ministry of Commerce recently.
Hyderabad: Pharmaceutical exports from India registered a growth of 4.22 percent to reach USD 14.57 billion during the April-October period despite a negative trend last month, according to a senior official of an export promotion body under the Government of India. Udaya Bhaskar, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), an organisation under the Ministry of Commerce, said he was hopeful of ending the current fiscal at around USD 27 billion as against USD 24.62 billion during the last financial year.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751